7,500 men tracked to see which prostate cancer screening saves lives
NCT ID NCT07155759
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 28 times
Summary
This study follows 7,500 men aged 50-74 to compare long-term outcomes of different prostate cancer screening methods. Some men were invited to a screening program using PSA, a biomarker test, and MRI, while others had only a single PSA test or were part of a control group. Researchers track who develops prostate cancer, who dies from it, and how many biopsies or MRIs are done, using registry data to see which approach works best.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Karolinska Institutet
Stockholm, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.